Karim Labib

8.8k total citations · 3 hit papers
75 papers, 6.7k citations indexed

About

Karim Labib is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Karim Labib has authored 75 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 31 papers in Cell Biology and 7 papers in Genetics. Recurrent topics in Karim Labib's work include DNA Repair Mechanisms (50 papers), Microtubule and mitosis dynamics (29 papers) and Genomics and Chromatin Dynamics (27 papers). Karim Labib is often cited by papers focused on DNA Repair Mechanisms (50 papers), Microtubule and mitosis dynamics (29 papers) and Genomics and Chromatin Dynamics (27 papers). Karim Labib collaborates with scholars based in United Kingdom, United States and Spain. Karim Labib's co-authors include John F.X. Diffley, Masato T. Kanemaki, Stephen Kearsey, Agnieszka Gambus, Alberto Sánchez‐Díaz, Giacomo De Piccoli, José Antonio Tercero, Frederick van Deursen, Ben Hodgson and Richard C. Jones and has published in prestigious journals such as Nature, Science and Nucleic Acids Research.

In The Last Decade

Karim Labib

75 papers receiving 6.6k citations

Hit Papers

GINS maintains association of Cdc45 with MCM in replisome... 2000 2026 2008 2017 2006 2000 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karim Labib United Kingdom 42 6.3k 1.8k 884 800 622 75 6.7k
Michael Lisby Denmark 42 6.0k 1.0× 951 0.5× 586 0.7× 880 1.1× 743 1.2× 117 6.5k
Philippe Pasero France 50 6.4k 1.0× 1.1k 0.6× 801 0.9× 1.1k 1.3× 646 1.0× 119 7.0k
Susan L. Forsburg United States 38 5.3k 0.8× 1.5k 0.9× 421 0.5× 492 0.6× 826 1.3× 114 5.9k
Michael N. Boddy United States 34 4.9k 0.8× 1.1k 0.6× 594 0.7× 936 1.2× 495 0.8× 52 5.2k
Paolo Plevani Italy 44 5.3k 0.9× 950 0.5× 709 0.8× 821 1.0× 529 0.9× 105 5.7k
Giovanna Lucchini Italy 42 3.9k 0.6× 1.0k 0.6× 428 0.5× 671 0.8× 530 0.9× 107 4.8k
Mark Goebl United States 28 4.7k 0.8× 1.4k 0.8× 529 0.6× 573 0.7× 798 1.3× 37 5.3k
Judith L. Campbell United States 53 7.7k 1.2× 768 0.4× 1.2k 1.3× 939 1.2× 895 1.4× 135 8.0k
Oscar M. Aparicio United States 34 6.9k 1.1× 720 0.4× 847 1.0× 374 0.5× 1.1k 1.8× 55 7.5k
Zuzana Štorchová Germany 35 3.5k 0.6× 2.1k 1.2× 812 0.9× 876 1.1× 876 1.4× 80 5.0k

Countries citing papers authored by Karim Labib

Since Specialization
Citations

This map shows the geographic impact of Karim Labib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Labib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Labib more than expected).

Fields of papers citing papers by Karim Labib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Labib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Labib. The network helps show where Karim Labib may publish in the future.

Co-authorship network of co-authors of Karim Labib

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Labib. A scholar is included among the top collaborators of Karim Labib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Labib. Karim Labib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villa, Fabrizio, et al.. (2025). USP37 protects mammalian cells during DNA replication stress by counteracting CUL2LRR1 and TRAIP. Cell Reports. 44(6). 115739–115739. 1 indexed citations
2.
Raimi, Olawale G., Verena Dederer, Sven M. Lange, et al.. (2024). Mechanism of human PINK1 activation at the TOM complex in a reconstituted system. Science Advances. 10(23). eadn7191–eadn7191. 17 indexed citations
3.
Evrin, Cécile, et al.. (2023). DONSON is required for CMG helicase assembly in the mammalian cell cycle. EMBO Reports. 24(11). e57677–e57677. 12 indexed citations
4.
Xia, Yisui, et al.. (2023). DNSN-1 recruits GINS for CMG helicase assembly during DNA replication initiation in Caenorhabditis elegans. Science. 381(6664). eadi4932–eadi4932. 22 indexed citations
5.
Evrin, Cécile, et al.. (2022). Spt5 histone binding activity preserves chromatin during transcription by RNA polymerase II. The EMBO Journal. 41(5). e109783–e109783. 17 indexed citations
6.
Fujisawa, Ryo, et al.. (2022). Multiple UBX proteins reduce the ubiquitin threshold of the mammalian p97-UFD1-NPL4 unfoldase. eLife. 11. 19 indexed citations
7.
Macartney, Thomas, et al.. (2021). Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. Biochemical Journal. 478(14). 2825–2842. 7 indexed citations
8.
Canal, Berta, Ryo Fujisawa, Tom Deegan, et al.. (2021). Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochemical Journal. 478(13). 2465–2479. 50 indexed citations
9.
Villa, Fabrizio, Ryo Fujisawa, Kohei Nishimura, et al.. (2021). CUL2 LRR1 , TRAIP and p97 control CMG helicase disassembly in the mammalian cell cycle. EMBO Reports. 22(3). e52164–e52164. 28 indexed citations
10.
Tan, Kang Wei, Mary Wu, Rachel Ulferts, et al.. (2021). Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease. Biochemical Journal. 478(13). 2517–2531. 42 indexed citations
11.
Xia, Yisui, et al.. (2021). TIMELESS‐TIPIN and UBXN‐3 promote replisome disassembly during DNA replication termination in Caenorhabditis elegans. The EMBO Journal. 40(17). e108053–e108053. 21 indexed citations
12.
Canal, Berta, Mary Wu, Rachel Ulferts, et al.. (2021). Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. Biochemical Journal. 478(13). 2445–2464. 32 indexed citations
15.
Evrin, Cécile, et al.. (2018). Histone H2A‐H2B binding by Pol α in the eukaryotic replisome contributes to the maintenance of repressive chromatin. The EMBO Journal. 37(19). 54 indexed citations
16.
Wu, Yuteng, Fabrizio Villa, Joseph D Maman, et al.. (2017). Targeting the Genome‐Stability Hub Ctf4 by Stapled‐Peptide Design. Angewandte Chemie. 129(42). 13046–13052. 2 indexed citations
17.
Sonneville, Romain, Sara Priego Moreno, Axel Knebel, et al.. (2017). CUL-2LRR-1 and UBXN-3 drive replisome disassembly during DNA replication termination and mitosis. Nature Cell Biology. 19(5). 468–479. 81 indexed citations
18.
Wu, Yuteng, Fabrizio Villa, Joseph D Maman, et al.. (2017). Targeting the Genome‐Stability Hub Ctf4 by Stapled‐Peptide Design. Angewandte Chemie International Edition. 56(42). 12866–12872. 24 indexed citations
19.
Bell, Stephen P. & Karim Labib. (2016). Chromosome Duplication inSaccharomyces cerevisiae. Genetics. 203(3). 1027–1067. 268 indexed citations
20.
Marić, Marija, Timurs Maculins, Giacomo De Piccoli, & Karim Labib. (2014). Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication. Science. 346(6208). 1253596–1253596. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026